國電科環(01296.HK)附屬組合營 從事冷能綜合利用運營及維護管理
國電科環(01296.HK)旗下於深交所上市的附屬公司龍源技術(300105.SZ)與中稷公司、中機國能簽署《關於成立「青島中稷龍源能源科技有限公司」投資協議》、《青島中稷龍源能源科技有限公司章程》,擬共同投資設立青島中稷龍源能源科技有限公司。
合資公司註冊資本為1,000萬元人民幣(下同),其中龍源技術以貨幣形式出資300萬元,佔股權比例30%;中稷公司以貨幣形式出資400萬元,佔比40%;中機國能以貨幣形式出資300萬元,佔比30%。
合資公司主要業務為冷能綜合利用的運營及維護管理,服務對象為石油化工行業LNG(液化天然氣)接收站。通過對LNG冷能的綜合利用,解決用冷和冷源無法處理的問題。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.